DANVITAL ApS: Financial statements 2019
CVR: 34595062
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
DANVITAL ApS (CVR 34595062) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -16,080 and a net result of DKK -32,749 compared with DKK -24,040 the year before. Equity in the 2019 report amounted to DKK -23,399.
- Gross Profit
- DKK -16,080
- Profit/Loss
- DKK -32,749
- Equity
- DKK -23,399
- Total Assets
- DKK 1,702
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -16 t. | -33 t. | -23 t. | - |
| 2018 | - | -17 t. | -24 t. | 9 t. | - |
| 2017 | - | -24 t. | -18 t. | 33 t. | - |
| 2016 | - | -14 t. | -9 t. | 51 t. | - |
| 2015 | - | -17 t. | -11 t. | 60 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
DANVITAL ApS has published its annual report for 2018. Gross profit came to DKK -16,701, and the net result was DKK -24,040.
About DANVITAL ApS
DANVITAL ApS was a Danish company of the type Anpartsselskab based in Svendborg, founded in 2012. The company has been dissolved on 25 January 2022. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2020, the company reported a gross profit of DKK -19,790 and a net result of DKK -19,803 compared with DKK -32,749 the year before. Equity in the 2020 report amounted to DKK -43,202.